Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: Facts and uncertainties underlying the causal link between animal and human diseases

Neurological Sciences

Volumn 25, Issue 3, 2004, Pages 122-129

  Beghi, E ^a,b   Gandolfo, C ^c   Ferrarese, C ^b   Rizzuto, N ^d   Poli, G ^e   Tonini, M C ^f   Vita, G ^g   Leone, M ^h   Logroscino, G ⁱ   Granieri, E ^j   Salemi, G ^k   Savettieri, G ^l   Frattola, L ^b   Ru, G ^l   Mancardi, G L ^c   Messina, C ^g  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d POLICLINICO BORGO ROMA   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f RHO HOSPITAL   (Italy)

^g UNIVERSITY OF MESSINA   (Italy)

^h MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^j UNIVERSITY OF FERRARA   (Italy)

^k UNIVERSITY OF PALERMO   (Italy)

^l NONE

more..

Author keywords

Bovine spongiform encephalopathy; Creutzfeldt Jakob disease; Epidemiology

Indexed keywords

AMYLOID;

BOVINE SPONGIFORM ENCEPHALOPATHY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CORRELATION ANALYSIS; CREUTZFELDT JAKOB DISEASE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; ELECTROENCEPHALOGRAM; HUMAN; INCIDENCE; NEUROPATHOLOGY; NONHUMAN; RETROSPECTIVE STUDY; REVIEW; SYMPTOMATOLOGY; VALIDATION PROCESS;

EID: 4344670042     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-004-0249-9     Document Type: Review

References (47)

1. Anderson RM, Donnelly CA, Ferguson NM et al (1996) Transmission dynamics and epidemiology of BSE in British cattle. Nature 382:779-788
2. Will RG, Ironside JW, Zeidler M et al (1996) A variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921-925
3. Zeidler M, Stewart G, Cousens SN et al (1997) Codon 129 genotype and variant CJD. Lancet 350:668
4. Brown P (2001) Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. Br Med J 322:841-844
5. Venters GA (2001) New variant Creutzfeldt-Jakob disease: the epidemic that never was. Br Med J 323:858-861
6. Hauw JJ, Sazdovitch V, Laplanche JL et al (2000) Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene. Neurology 54:1641-1646
7. Parchi P, Giese A, Capellari S et al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224-233
8. Will RG, Zeidler M, Stewart GE et al (2000) Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 47:575-582
9. Will RG, Matthews WB (1984) A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-1979. I. Clinical features. J Neurol Neurosurg Psychiatry 49:134-140
10. Laprevotte I, Henaut A (2003) The new variant of the Creutzfeldt-Jakob disease accounts for no relative increase of the Creutzfeldt-Jakob disease mortality rate in the United Kingdom; this fits ill with the new variant being the consequence of consumption of food infected with the agent of bovine spongiform encephalopathy. BMC Publ Health 3:25-29
11. Lasmezas CI, Deslys JP, Demalmay R et al (1996) BSE transmission to macaques. Nature 381:743-744
12. Collinge J, Sidle KCL, Heads J et al (1996) Molecular analysis of prion strain variation and the etiology of 'new variant' CJD. Nature 383:685-690
13. Bruce ME, Will RG, Ironside JW et al (1997) Transmissions to mice indicate that 'variant' CJD is caused by the BSE agent. Nature 389:498-501
14. Scott MR, Will RG, Ironside JW et al (1999) Compelling transgenic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci USA 26:15137-15142
15. Hill AF, Joiner S, Linehan J et al (2000) Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci USA 18:10248-10253
16. Will RG, Alperovitch A, Poser S et al (1998) Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. Ann Neurol 43:763-767
17. Nakamura Y, Yanagawa H, Hoshi K et al (1999) Incidence rate of Creutzfeldt-Jakob disease in Japan. Int J Epidemiol 28:130-134
18. Cousens SN, Zeidler M, Esmonde TF et al (1997) Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96. Br Med J 315:389-395
19. Wientjens DPWM, Davanipour Z, Hofman A et al (1996) Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies. Neurology 46:1287-1291
20. Van Duijn CM, Delasnerie-Laupretre N, Masullo C et al (1998) Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. Lancet 351:1081-1085
21. Van Duijn CM, Delasnerie-Laupretre N, Masullo C et al (2001) Creutzfeldt-Jacob disease surveillance in the UK. National CJD Surveillance Unit, Edinburgh and Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London (www.cjd. ed.ac.uk/rep2001.html, accessed 3 June 2004)
22. Masters CL, Harris JO, Gadjusek DC et al (1979) Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 5:177-188
23. Cathala F, Brown P, Castaigne P, Gadjusek DC (1979) La maladie de Creutzfeldt-Jakob en France continentale. Etude retrospective de 1968-1977. Rev Neurol 5:439-454
24. Concerted action of the EU (1994) Surveillance of Creutzfeldt-Jakob disease in the European community. Minutes of the second meeting in Rome, July 3 1993, and the third meeting in Paris, April 29-30
25. Brandel JP, Delasnerie-Laupetre N, Laplanche JL et al (2000) Diagnosis of Creutzfeldt-Jakob disease. Effect of clinical criteria on incidence estimates. Neurology 54:1095-1099
26. Zerr I, Bodemer M, Gefeller O et al (1998) Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 43:32-40
27. Hsich G, Kenney K, Gibbs CJ et al (1996) The 14-3-3 brain protein in cerebrospinal fluid as a marker of transmissible spongiform encephalopathies. N Engl J Med 335:924-930
28. Van Everbroeck B, Quoilin S, Boons J et al (2003) A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 74:1210-1214
29. Zerr I, Pocchiari M, Collins S et al (2000) Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 55:811-815
30. Lemstra AW, van Meegen MT, Vreyling JP et al (2000) 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease. A prospective study in 112 patients. Neurology 55:514-516
31. Burkhard PR, Sanchez JC, Landis T, Hochstrasser DF (2001) CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology 56:1528-1533
32. Zeidler M, Stewart GE, Barraclough CR et al (1997) New variant Creutzfeltd-Jakob disease: neurological features and diagnostic tests. Lancet 350:903-907
33. Schwaninger M, Winter R, Hacke W et al (1997) Magnetic resonance imaging in Creutzfeldt-Jakob disease: evidence of focal involvement of the cortex. J Neurol Neurosurg Psychiatry 63:408-416
34. Schwaninger M, Winter R, Hacke W et al (1996) Report of a WHO consultation on public health issues related to human and animal transmissible spongiform encephalopathies. WHO, Geneva
35. Hill AF, Butterworth RJ, Joiner S et al (1999) Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353:183-189
36. Shlesselman JJ (1982) Case-control studies. Design, conduct, analysis. Oxford University, New York
37. Cousens SN, Linsell L, Smith PG et al (1999) Geographical distribution of variant CJD in the UK (excluding Northern Ireland). Lancet 353:18-21
38. Glatzel M, Rogivue C, Ghani A, Streffer JR, Amsler L, Aguzzi A (2002) Incidence of Creutzfeldt-Jakob disease in Switzerland. Lancet 360:139-141
39. Asante EA, Linehan JM, Desbruslais M et al (2002) BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 21:6358-6366
40. Kimberlin RH, Wilesmith JW (1994) Bovine spongiform encephalopathy: epidemiology, low dose exposure and risks. Ann N Y Acad Sci 724:210-220
41. Andrews NJ, Farrington CP, Ward HJ et al (2003) Deaths from variant Creutzfeldt-Jakob disease in the UK. Lancet 361:751-752
42. Ghani AC (2002) The epidemiology of variant Creutzfeldt-Jakob disease in Europe. Microbes Infect 4:385-393
43. Goldfarb LG (2002) Kuru: the old epidemic in a new mirror. Microbes Infect 4:875-882
44. Cousens SN, Vynnycky E, Zeidler M et al (1997) Predicting the CJD epidemic in humans. Nature 385:197-198
45. Ghani AC, Ferguson NM, Donnelly CA, Anderson RM (2000) Predicted vCJD mortality in Great Britain. Nature 406:583-584
46. MacNaughton HN, Will RG (1997) Creutzfeldt-Jakob disease presenting acutely as stroke: an analysis of 30 cases. Neurol Infect Epidemiol 2:19-24
47. Verity CM, Nicoll A, Will RG et al (2000) Variant Creutzfeldt-Jakob disease in UK children: a national surveillance study. Lancet 356:1224-1227